Core Viewpoint - The Schall Law Firm is investigating Aldeyra Therapeutics, Inc. for potential violations of securities laws following a significant drop in share price after the FDA issued a Complete Response Letter regarding the company's drug reproxalap [1][2]. Group 1: Investigation Details - The investigation centers on whether Aldeyra made false or misleading statements or failed to disclose critical information to investors [2]. - On April 3, 2025, Aldeyra announced that the FDA's Complete Response Letter indicated that the NDA for reproxalap "failed to demonstrate efficacy in adequate and well controlled studies in treating ocular symptoms associated with dry eyes" [2]. - Despite Aldeyra's claims of "uniquely supportive" clinical trial data, the FDA expressed concerns regarding the trial data submitted as part of the NDA [2]. Group 2: Market Impact - Following the FDA's announcement, Aldeyra's shares plummeted by nearly 75% during trading on the same day [2].

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating TechTarget, Inc. (Nasdaq: TTGT) for potential securities law violations. Investors who have lost money in their TechTarget investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/ttgt. What is this all about? TechTarget announced a delay in filing its 2024 Annual Report and disclosed plans to record a significant goodwill impairment. This foll ...

Core Viewpoint - The Schall Law Firm is investigating OSI Systems, Inc. for potential violations of securities laws, particularly concerning misleading statements and undisclosed information related to the company's operations and financial performance [1][2]. Group 1: Investigation Details - The investigation centers on whether OSI Systems issued false or misleading statements and failed to disclose critical information to investors [2]. - A report by Culper Research claims that OSI Systems' reported revenue growth in Mexico is "largely an illusion" and suggests that the company has minimized the significance of a Department of Justice (DOJ) investigation through vague disclosures [2]. Group 2: Legal Representation - The Schall Law Firm offers free consultations for shareholders who believe they have suffered losses due to the alleged misconduct of OSI Systems [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].